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ABSTRACT 
Amyotrophic Lateral Sclerosis (ALS) is a debilitating and rare disorder; progressively the 
patient’s muscles go into paralyses limiting their ability to walk, do day-to-day tasks, and eat.  
This thesis covers risk factors related to ALS.  In Sweden, we investigated different types of 
head injuries, fractures and occupational metal and chemical exposures (using a job exposure 
matrix).  In the United States, we looked at different levels of selenium (Se), zinc (Zn), 
copper (Cu) and manganese (Mn) found in human blood. 
Study I investigates severe head injury and ALS within the Swedish population.  
Additionally, we investigated repeated head injury and subtypes of head injury and how these 
are associated with the risk of ALS.  We found that there was an association with severe head 
injury and the risk of ALS ≤ 1 year before diagnosis.  No associations were found > 3 years 
before ALS diagnosis suggesting no strong support for the association between head injury 
and ALS. 
Study II investigates blood levels of trace metals (Se, Zn, Cu, and Mn) and the risk of ALS 
in United States military veterans.  Specifically, we examined the risk of ALS with these 
metals, how ALS and metal associations varied by clinical features, and how lead effected the 
associations of metals and ALS.  Interestingly, we found inverse associations with Se and Zn 
in relation to the risk of ALS. Cu was positively associated with ALS, although, adjustment 
for Pb attenuated this association.  We found several inverse associations with Se and ALS, 
and a few with Zn and ALS by different clinical features. 
Study III investigates occupational exposures and the risk of ALS in the Swedish population.  
Uniquely, we used the Nordic Occupational Cancer Study Job Exposure Matrix to identify 
occupational exposures.  We did not find occupational exposures to be associated with the 
risk of ALS in the general population.  However, we did find a positive association with 
formaldehyde and an inverse association with methylene chloride with the risk of ALS; this 
was only among those that were 65 years of age or younger. 
Study IV investigates the association of the incidence of ALS with fractures; we examined 
any fracture (minus head and face), osteoporotic/non-osteoporotic fractures, and fractures 
related/not related to trauma.  We found that all examined fractures were associated with an 
increased incidence of ALS.  Any fractures (minus head and face) were consistently 
associated with a higher incidence of ALS from one to eighteen years after fracture diagnosis. 
  
In conclusion, our studies show that certain risk factors for ALS can offer insight into the 
disease etiology and pathophysiology.  Bone health is important in relation to ALS and 
supplementation of Se and Zn might be beneficial for ALS patients.  
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LIST OF ABBREVIATIONS 
These abbreviations can be found in this thesis as well as in the four papers.   
 
AIC  Akaike information criterion 
ALS   Amyotrophic lateral sclerosis 
ALSFRS-R  Revised ALS functional rating scale 
APOE  Apolipoprotein E 
CI  Confidence interval 
CSF  Cerebral spinal fluid  
CTE  Chronic traumatic encephalopathy 
Cu  Copper 
EMF  Electromagnetic fields 
fALS  Familial amyotrophic lateral sclerosis 
GENEVA  Genes and Environmental Exposures in Veterans with ALS 
HRs  Hazard ratios 
ICD  International Classification of Diseases 
ICPMS  Inductively coupled plasma mass spectrometry 
IPR   Inpatient Register 
JEM  Job exposure matrix 
LMN  Lower motor neuron 
MN  Manganese 
MND   Motor neuron disease 
NHANES   National Health and Nutrition Examination Survey 
NOCCA  Nordic Occupational Cancer Study 
NOCCA-JEM Nordic Occupational Cancer Study job exposure matrix 
NPR  National Patient Register 
NS  Not statistically significant 
OPR  Outpatient Register 
OR   Odds ratio 
Pb   Lead 
PIN  Personal identity number 
PRN  Personal registration number 
RBCs  Red blood cells 
RR   Relative risk 
SD   Standard deviation 
  
Se   Selenium 
SOD1   Superoxide dismutase 1 
TDP-43  Transactive response DNA binding protein 43 kDa 
UMN  Upper motor neuron 
VA   Department of Veterans Affairs 
VALE   Veterans with ALS and Lead Exposure 
Zn   Zinc 
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1 INTRODUCTION 
The neurodegenerative disease amyotrophic lateral sclerosis (ALS) involves dysfunction of 
both the lower and upper motor neurons in the body (Al-Chalabi and Hardiman, 2013).  
Patient’s muscles become weak and spastic, giving rise to a series of problems (Kiernan et 
al., 2011).  The patient slowly loses the ability to walk and move their arms and hands.  It can 
become difficult for the patient to speak, eat and breathe, and some patients experience 
psychological symptoms (depression and some cognitive dysfunction) (Kiernan et al., 2011). 
This disease is rare (with an incidence of 1-2 per 100,000 person-years) and occurs all over 
the world (Chiò et al., 2013).  For the majority of ALS patients (about 90%), the disease is 
sporadic, with no definitive cause (Kiernan et al., 2011).  For about 10% of patients, the 
disease is genetic (Ingre et al., 2015).  Most patients survive only 2-5 years since symptom 
onset, with only a few patients surviving more than 10 years (Ingre et al., 2015). Currently, 
there is no cure for this disease (Ingre et al., 2015).  Riluzole is one of the only drugs known 
to delay the progression of ALS by about 2 to 3 months (Ingre et al., 2015).  Not only does 
this disease affect the patients themselves, but it also affects caregivers (Kiernan et al., 2011).  
Depending on the severity of ALS, caregivers often accompany patients to doctors’ visits, 
help with day-to-day tasks, and help carry the patient emotionally (Pagnini et al., 2010).  
Furthermore, patients and caregivers often rearrange their households to fit the needs of the 
patient (Pagnini et al., 2010). The main known risk factors for the disease are genetics, 
gender, and age (Oskarsson et al., 2015).  The purpose of this thesis was to investigate 
different risk factors for ALS, which can give new information to the field.  
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2 BACKGROUND 
2.1 AMYOTROPHIC LATERAL SCLEROSIS 
 
2.1.1 Diagnosis 
 
Symptoms of ALS may include: muscle weakness and spasticity, pain, constipation, 
difficulty speaking, difficulty swallowing, shortness of breath, cognitive problems, depression 
and anxiety, and sleep problems (Kiernan et al., 2011).  There is no biological marker for the 
diagnosis of ALS (Kiernan et al., 2011).  However, diagnostic criteria was last established in 
2000, the El Escorial criteria (Brooks et al., 2000).  For a clinician to give a diagnosis of 
ALS, there are several things they have to consider; first, there has to be an absence of other 
diseases based on the neuroimaging, electrophysiological and pathological findings and 
second, there has to be evidence of lower motor neuron (LMN) signs (electrophysiological, 
neuropathologic or clinical examination), upper motor neuron (UMN) signs (clinical 
examination) and disease symptoms have to spread to different areas or within the same area 
(Brooks et al., 2000).  LMN signs include weakness, fasciculations, and atrophy and UMN 
signs include the pathological spread of reflexes (Brooks et al., 2000).  These signs can occur 
in four central nervous system regions: the brain stem, lumbosacral, thoracic, and cervical 
(Brooks et al., 2000).      
 
2.1.2 Epidemiology 
 
About 5-10% of ALS cases have a family history, while for the other 90% of the patients 
(sporadic ALS cases) the etiology is unknown (Ingre et al., 2015).  ALS most commonly 
occurs in people between the ages of 55 – 70, with incidence increasing with age (Chiò et al., 
2013).  ALS is more common in men than women (Al-Chalabi and Hardiman, 2013).  The 
median level of incidence rates in North America and Europe was about the same (about two 
per 100,000 person-years), whereas the incidence rates in Asia were slightly lower (about one 
per 100,000 person-years) (Figure 1) (Chiò et al., 2013).  
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 Figure 1.  
 
The median level of prevalence rates in North America was lower than (about three per 
100,000 persons) Europe (about five per 100,000 persons), whereas Asia had slightly higher 
rates (about six per 100,000 persons) (Figure 2) (Chiò et al., 2013).   
Figure 2.  
 
 
2.2 RISK FACTORS FOR AMYTROPHIC LATERAL SCLEROSIS 
 
 
There have been quite a few risk factors that have been investigated in relation to ALS (Ingre 
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injury, metabolic diseases, cancer, neuroinflammation, β-N-methylamino-L-alanine, viral 
infections, electromagnetic fields, smoking, US military service, pesticides, body mass index, 
statin treatment, and region (Ingre et al., 2015; Oskarsson et al., 2015).  
 
2.2.1 Genetics, Gender and Age 
 
Genetics, gender and age are the strongest risk factors for ALS (Oskarsson et al., 2015).  
Familial ALS (fALS) is defined as those that have a hereditary connection to their disease 
(Ingre et al., 2015).  Clinically, fALS is similar to sporadic ALS (Robberecht and Philips, 
2013).  There are about 17 known genes that make up 70% of fALS (Al-Chalabi and 
Hardiman, 2013).  There is about a 1.5 times increased risk of ALS for being male versus 
being a female; males and females differ genetically, and in how they interact with their 
environment, which may affect their risk (Oskarsson et al., 2015).    
Advanced age is another strong risk factor (Oskarsson et al., 2015).  ALS can start as early as 
age 30; however, the majority of ALS patients develop ALS around age 55-70 (Chiò et al., 
2013).  There is a decline of the incidence of ALS after the age of 80-90 (Oskarsson et al., 
2015).  This decline may be due to the fact that initial symptoms (muscle weakness and 
wasting) may be recognized as a part of older age or can be ignored because a patient has 
other co-existing diseases (Al-Chalabi and Hardiman, 2013).   
 
2.2.2 Head Injury 
 
There have been different kinds of studies done on head injury and ALS; most have yielded 
mixed results (Chen et al., 2007; Fournier et al., 2015; Mckee et al., 2010; Pearce et al., 2015; 
Turner et al., 2010).  Head injury in relation to ALS has been explored in high impact sports, 
different populations, and in the neuropathological condition, chronic traumatic 
encephalopathy (CTE) (Chen et al., 2007; Chio et al., 1991; Fournier et al., 2015; Kondo and 
Tsubaki, 1981; Lehman et al., 2012; Mckee et al., 2010; Savica et al., 2012).  It is thought 
that head injury can trigger underlying mechanisms that cause ALS or that it might accelerate 
the already existing disease (Armon and Albert, 2015).   
Sports (football and soccer) have been associated with the risk of ALS; hypotheses to explain 
this elevated risk are head injury or CTE (Pearce et al., 2015).  However, other hypotheses 
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have been noted, such as: misuse of drugs, physical exercise, and potential environmental 
toxins (Chio et al., 2005; Pearce et al., 2015). Most recently, a study investigated causes of 
death among United States Football League players; the investigators found that ALS 
mortality was four times higher among these football players than the US general population 
(Lehman et al., 2012). 
An extension of head injury is the neuropathological condition CTE, which has been 
associated with ALS (Fournier et al., 2015; Mckee et al., 2009).  Mckee et al. (2010) found 
that three of the professional athletes (out of twelve) who had experienced multiple head 
injuries and a diagnosis of CTE also had a diagnosis of motor neuron disease (MND).  In 
these three MND cases, they found TDP-43 (transactive response DNA binding protein 
43 kDa); TDP-43 is thought to be associated with MND.  A recent ALS study looked at head 
injury progression and neuropathologic outcomes to extend upon these results; the authors 
found that tau proteinopathy was found in both ALS cases with and without head injury and 
that head injury did not accelerate the disease (Fournier et al., 2015). 
 
2.2.3 Metals 
 
Metals in general are thought to have a role in ALS.  Metals can be essential for the body, as 
they are found in what we eat, and are found in our environment.  However, when a person is 
over or under exposed to the metals, the metals often produce negative effects.  At high doses 
it can affect the nervous system and it can accumulate in the brain (affecting the hippocampus 
and other regions) (Chen et al., 2016).  Metals can cause oxidative stress and impair enzymes; 
mitochondria can become dysfunctional, and proteins can misfold and cause several other 
effects (Chen et al., 2016).  Most ALS studies have evaluated the toxic effects of metals at 
high levels of exposure and have reported that metal exposure is positively associated with 
ALS (Bergomi et al., 2002; Nagata et al., 1985).  Metal deficiencies might also play an 
important role in the etiology of ALS, but only Zn deficiency has been studied (Trumbull and 
Beckman, 2009).   
Lead (Pb) is a metal that is/has been used in gasoline, water pipes, paint, construction and 
other commonly used items (Pfadenhauer et al., 2016).  First, environmental lead is initially 
absorbed to the blood, then small amounts of lead are excreted through urination, and finally, 
the majority of the lead will be stored in soft tissues and bones.  Environmental exposures to 
lead have decreased in the last few decades (Pfadenhauer et al., 2016).  This has caused a 
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decline in blood lead.  Pb has been found to be toxic at high levels (Fang et al., 2010; Kamel 
et al., 2002; Kamel et al., 2005). 
 
Since Pb affects the nervous system it is thought to have a role in ALS.  Pb has been 
frequently explored in studies of ALS and has been found to be positively associated with 
ALS (Fang et al., 2010; Kamel et al., 2005).  Studies of other metals, including selenium (Se), 
zinc (Zn), copper (Cu) and manganese (Mn) have yielded inconsistent results because of 
small sample sizes and variations in study design and the tissues in which metals were 
measured (Bergomi et al., 2002; Pamphlett et al., 2001; Roos et al., 2013). 
Selenium (Se) is a trace element.  Most people are exposed to Se through diet; different 
levels of exposure can be due to various food content, region, and weather (Navarro-Alarcon 
and Cabrera-Vique, 2008).  Other sources of exposure to Se, such as occupation and drinking 
water, are rare (Navarro-Alarcon and Cabrera-Vique, 2008).  Studies of Se and ALS risk 
have mostly reported positive associations or no associations (Nagata et al., 1985; Pamphlett 
et al., 2001; Roos et al., 2013).  Studies of swine have shown that Se has a specific toxicity to 
motor neurons; this is the most convincing biological link between Se and ALS to date 
(Vinceti et al., 2010).   
Zinc (Zn) is a trace element.  Zn is essential for nerve conduction, brain development and 
function (Smith and Lee, 2007).  Oxidative stress is one mechanism thought to play a role in 
ALS pathophysiology (Wijesekera & Leigh, 2009).  Only a few studies have evaluated the 
relationship of Zn with ALS and results are mixed (Bergomi et al., 2002; Pamphlett et al., 
2001; Roos et al., 2013).  A study in Australia reported no difference in Zn levels in plasma, 
red blood cells, and whole blood among 20 sporadic ALS cases and 20 controls (Pamphlett et 
al., 2001).  A study conducted in Norway found higher cerebrospinal fluid (CSF) Zn 
concentrations in 17 ALS cases than 10 controls (Roos et al., 2013).   
Copper (Cu) is a trace element with an important role in the nervous system; both excess and 
deficiency can be deleterious (Rivera-Mancia et al., 2010).  It has been suggested that 
neuronal Cu deficiency can cause neuronal degeneration; they found that axonal swelling in 
rats caused by the chemical iminodipropionitrile was due to its ability to chelate Cu (Hartman 
and Everson, 1992).  Roos et al. (2013) reported higher CSF Cu concentrations in 17 ALS 
cases than 10 controls in Norway.   Kapaki et al. (1997) found decreased levels of CSF and 
serum Cu in 28 sporadic ALS cases compared to 38 controls in Greece.    
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Manganese (Mn) is a trace element.  Mn is important for bone formation, normal growth and 
development, blood sugar regulation, fat and carbohydrate metabolism, cellular homeostasis, 
and calcium absorption (Bowman et al., 2011).  Mn is also neurotoxic at high concentrations 
(Kihira et al., 1990).  Mn crosses the blood-brain barrier and then concentrates in the central 
nervous system (Roos et al., 2012).  Results from the studies of Mn in relation to ALS are 
mixed (Kapaki et al., 1997; Nagata et al., 1985; Roos et al., 2013).  
 
2.2.4 Occupational Exposures 
 
 
Occupational exposures can be assessed via interviews.  For example, a study collected 
occupational history and found certain jobs associated with Pb exposure; these jobs included 
soldering, painting, paint removal, battery manufacturing or reclamation, and working with a 
firearm or on a firing range (Kamel et al., 2005).  Additionally, occupational exposures can 
also be assessed via a job exposure matrix (JEM).  A JEM links a series of occupations to 
create an occupational exposure.   Only a few exposures have been studied among JEM 
studies of ALS, and these include physical activity, electromagnetic fields, and electric shock 
(Fischer et al., 2015; Longstreth et al., 1998; Zhou et al., 2012).  
Different occupational exposures such as lead, formaldehyde, pesticides, solvents, other 
metals, and infectious agents (military) have been suggested to be associated with the risk of 
ALS previously (Fang et al., 2009; Haley, 2003; Kamel et al., 2005; Kamel et al., 2012; 
Malek et al., 2014; Weisskopf et al., 2009).  In general, there have been a few studies to 
investigate occupations and occupational exposures with ALS or MND risk in Sweden 
previously (Feychting et al., 2003; Fischer et al., 2015; Gunnarsson et al., 1991; Gunnarsson 
et al., 1992).   
 
2.2.5 Occupations 
 
Occupations can provide us clues into ALS etiology.  Researchers have reported that many 
different occupations contribute to an increased risk of ALS; these workers include:  farmers, 
veterinarians, health care workers, hairdressers, electrical workers, power-production plant 
operators, athletes, military service workers, construction workers, heavy laborers, and 
workers employed in the plastics industry (Gunnarsson et al., 1991; Sutedja et al., 2007; 
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Sutedja et al., 2009; Weisskopf et al., 2005).  However, there have been inconsistent results 
for some occupations (military service, farming and agricultural work) (Gunnarsson et al., 
1991; Sutedja et al., 2007; Sutedja et al., 2009; Weisskopf et al., 2005). 
 
 
2.2.6 Fractures 
 
Fractures have been investigated previously in relation to ALS, including more specific 
fractures (such as wrist, hand, head, neck, and foot), multiple fractures, traumatic fractures, 
any fracture, and fractures a few years before symptom onset or diagnosis; results have been 
mixed (Angelini et al., 1983; Cruz et al., 1999; Gresham et al., 1986; Pupillo et al., 2012).  
Studies tend to relate fractures with trauma.  Physical trauma, including fracture, has been 
proposed to be related to ALS, but study results are inconsistent and the subject is 
controversial (Armon, 2007; Beghi et al., 2010; Cruz et al., 1999).  
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3 AIMS 
 
The aim of this thesis was to explore different types of risk factors for ALS. 
 
 
 
 
• Study I: To examine severe head injury as a risk factor for ALS in Sweden.  
     
 
• Study II:  To examine trace metals (selenium, zinc, copper and manganese)
 and the risk of ALS in United States military veterans. 
 
 
• Study III:  To examine occupational exposures and the risk of ALS in 
 Sweden. 
 
 
• Study IV:  To examine the association of different types of fractures with 
 ALS in Sweden.  
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4 METHODS 
4.1 SWEDISH DATA SOURCES 
 
4.1.1 Swedish Population and Household Census 
 
The Swedish Population and Housing Censuses started in 1960 by Statistics Sweden and 
have been carried out every five years.  The last Swedish population and housing census was 
carried out in 1990.  These censuses contain information from a questionnaire about gender, 
personal registration number (PRN), occupation, birthdate, education, household size, marital 
status, and citizenship (Lagerlund, 2005).  The PRN is a number that each registered resident 
of Sweden receives. 
4.1.2 National Patient Register (NPR) 
 
The National Board of Health and Welfare started the National Patient Register (NPR) in 
1964/1965 and collected information about diseases (International Classification of Diseases 
(ICD), dates of admission, and dates of discharge.  Nationwide coverage began in 1987 and 
continued onward.  Initially, data was collected from inpatient visits (Inpatient Register 
(IPR)); however, from 2001, the NPR started to collect information from hospital outpatient 
visits/specialist visits (Outpatient Register (OPR)) (Ludvigsson, 2011).  ALS diagnoses were 
identified using ICD codes (ICD-ninth revision, 335C and ICD-tenth revision, G12.2).  It is 
valid to use hospital data for ALS diagnoses and in the NPR the diagnoses are of high quality 
(Ludvigsson et al., 2011; Kurian et al., 2009; St Germaine-Smith et al., 2012).   
4.1.3 Cause of Death Register 
 
Since 1952, The National Board of Health and Welfare has organized and maintained the 
Cause of Death Register.  This register contains information about the age of death, cause of 
death, and date of death (Ludvigsson, 2011).    
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4.1.4 Migration Register 
 
For residents who are registered in Sweden, immigration and emigration dates are recorded 
and updated every few months. 
4.1.5 Swedish Education Register 
 
For all residents who are between 17-64 years old, information is updated annually about 
highest level of education and completion year. 
 
 
Figure 3. Swedish Registers Used for Exposure and Outcome in Studies I, III and IV 
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4.2 UNITED STATES MILITARY DATA 
 
4.2.1 Veterans with ALS and Lead Exposure (VALE) 
 
 
Cases for this dataset consisted of military veterans that came from the US Department of 
Veterans Affairs National Registry of Veterans with ALS (Veterans Affairs Registry) (Allen 
et al., 2008).  To become a part of this registry, there was a telephone screening questionnaire 
that veterans or their caretakers had to pass and they were then asked to provide medical 
records and to donate blood to a DNA bank (about half of the veterans donated blood) 
(DiMartino et al., 2007).  Medical records were reviewed by neurologists who specialized in 
MND and they assigned a diagnosis based on the revised El Escorial criteria (Brooks et al., 
2000).  MND diagnoses included clinically definite ALS, probable ALS, possible ALS, 
progressive muscular atrophy, and primary lateral sclerosis.  A subgroup of VA registry 
patients donated blood samples during January and September 2007 and was included in the 
VALE study.   
 
4.2.2 Genes and Environmental Exposures in Veterans with ALS 
 
 
Controls for the VALE dataset came from the Genes and Environmental Exposures in 
Veterans with ALS (GENEVA) study (Schmidt et al., 2008).  In June of 2005 an age-
stratified random sample of 10,000 controls were obtained from the Veterans Benefit 
Administration and then the GENEVA study selected controls.  When controls were 
identified they had to be free from ALS and other neurological disorders.  These controls 
were additionally frequency matched to GENEVA patients on age (age at interview for 
controls and age at diagnosis for patients, had to be within 5 years of each other) and use of 
the VA health care system (before interview/diagnosis).  Controls already enrolled in 
GENEVA were selected and invited to participate in VALE; between May 2007 and May 
2008, they were asked to donate blood and give informed consent.    
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4.3 STUDY DESIGN 
 
4.3.1 Study I 
 
4.3.1.1 Initial Cohort 
 
The initial study cohort consisted of 5,764,522 Swedish individuals who participated in the 
1990 Swedish Population and Housing Census and were born between 1901 and 1970.  
Registers (the Swedish Population and Housing Census, NPR, Migration Register, and the 
Cause of Death Register) were linked together via PRNs.  Before entry into the cohort, 
excluded individuals included those who emigrated out of Sweden, died, or had a diagnosis 
of ALS.  Follow-up of the study population started from January 1
st
, 1991 and ended 
(whichever came first) if an individual migrated out of Sweden, died, had an diagnosis of 
ALS or came to the end of follow-up (December 31
st
, 2007).   
 
4.3.1.2 Nested Case-Control Study 
A nested case-control study was conducted within the above-mentioned study cohort. 
 
4.3.1.3 Cases and Controls 
Cases  
The first hospital diagnosis date of ALS was defined as a cases index date.  There were 4,004 
ALS cases identified from the NPR during follow-up, with diagnosis dates (main or 
secondary diagnosis date at specialist visit or discharge) coming from the IPR and the OPR.  
ALS diagnoses were identified using ICD codes. 
Controls 
Using incidence density sampling, 20,020 controls were randomly selected (five per ALS 
case).  Furthermore, controls had to be in Sweden and alive at the cases’ index dates.  
Controls were also matched on birth year and gender to ALS cases.    
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4.3.1.4 Exposure 
 
Severe head injury diagnosis dates (main and secondary diagnosis dates before index date) 
were examined only through the IPR.  ICD codes for head injury (fracture, concussion, 
hemorrhage, and contusion) diagnoses included: ICD-9: 800, 801, 803, and 850- 854; ICD-
10: S020, S021, S027-S029, and S060-S071. 
 
4.3.1.5 Statistical Analyses 
 
We examined severe head injury, repeated head injuries and subtypes of head injury before 
index date by using conditional logistic regression models to estimate odds ratios (ORs) and 
95% confidence intervals (CIs).  All models were adjusted for socioeconomic status and 
region of residence within Sweden.  Repeated head injuries were defined as multiple 
hospitalizations for a different head injury; if a patient was transferred among different clinics 
for one injury it was considered to be one hospital visit.  Additionally, we examined head 
injuries, before index date, in different time windows to see if a temporal relationship existed 
between ALS and head injury.  Before 2001, ALS diagnosis dates were limited to the IPR, 
which means there could be a lag between ALS onset date to first IPR date.  To correct for 
this we did an additional analysis by examining head injuries > 3 years before the index date.   
 
4.3.2 Study II 
 
4.3.2.1 Cases and Controls 
Cases 
We only included in our analyses ALS patients with a diagnosis of clinically possible, 
probable or definite ALS (163 cases).  
Controls 
Controls who donated blood (229) were included in the study. 
 
4.3.2.2 Exposure 
An additional blood sample (using 6-mL BD Vacutainer blue-top Trace Element metal-free 
tube (Becton, Dickinson and Company, Franklin Lakes, New Jersey)) was collected for 
VALE patients, and the collection procedures were the same for VA Registry patients (Allen 
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et al., 2008).  Two samples (a 6-mL whole blood sample in a metal-free tube, collected first, 
and a 9-mL plasma sample) were collected during home visits for VALE controls.  Blood 
samples from cases and controls were processed in the same way; blood samples were 
shipped cold to the lab where plasma was separated, then the samples were frozen and stored 
until assay.   
 
Inductively coupled plasma mass spectrometry (ICPMS) was used to determine metal (Se, 
Zn, Cu, Mn and Pb) concentrations in 1.0 ml blood (Fang et al., 2010).  Using a class 100 
plastic hood and trace metal-free agents (oxidants, 18-MΩ-quality deionized water, and 
ultrex-grade acids) sample contamination was kept low.  Limits of detection were 0.113 μg/dl 
for Se, 6.24 μg/dl for Zn, 0.234 μg/dl for Cu, and 0.124 μg/dl for Mn and there was good 
assay precision.   
 
Precision was additionally checked by undergoing analysis and preparation twice for both 
cases and controls (for a subset of samples).  Values for reagent blanks were below the 
detection limit for Se, Zn, Cu, and Mn.  Spiked blood samples were used to evaluate percent 
relative error (68% for Se, 5% for Zn, −17% for Cu, and −8% for Mn).     
 
4.3.2.3 Statistical Analyses 
 
To investigate ALS or MND in association with metals in the blood (we used both 
continuous and categorical variables) unconditional logistic regression models were used to 
derive ORs and 95% CIs. Continuous variables were log2-transformed for appropriate model 
fit (for all metals) and Ptrend was assessed for Mn.  Categories of metal levels were created 
using quintiles of the metal levels in the blood among controls and the lowest quintile level 
was used as reference.  Model fit was assessed using the Akaike information criterion (AIC).  
For all models we adjusted for gender, age (continuous), and race/ethnicity.  For some models 
we additionally adjusted for Pb, smoking, or other metals.   
 
Multinomial logistic regression models were used to assess the association of metals with 
ALS or MND and how these associations varied among clinical features.  Three outcomes 
existed for the multinomial logistic regression model we used; the two disease sub-groups, 
were defined by dichotomized collection delay, dichotomized diagnostic delay, dichotomized 
ALSFRS-R score, and by site of onset (bulbar or spinal). These models were adjusted for 
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race/ethnicity and age (continuous), while gender was not used as an adjustment factor 
because the number of females in the study was too small (n=3).     
 
4.3.3 Study III 
 
4.3.3.1 Nested Case-Control Study 
A nested case-control study was conducted within a study population that included all 
individuals registered in the 1990 Swedish Population and Household Census (born between 
1901 and 1970).  Register data (Swedish Population and Household Census, NPR, Migration 
Register, Cause of Death Register) were linked via PRNs, to create the study cohort, and 
within the cohort, a nested case-control study was performed.  Follow-up started on January 
1
st
, 1991 and ended on December 31
st
, 2010.  During follow-up, whichever came first, people 
could be censored for migrating out of Sweden, death, first date of ALS diagnosis or 
December 31
st
, 2010.   
 
4.3.3.2 Cases and Controls 
Cases 
During follow-up, 5,020 ALS patients were identified from the NPR (both inpatient and 
outpatient registers) with the first known primary or secondary ALS diagnosis from ICD 
codes.   
 
Controls 
 
From the study population, 25,100 controls were randomly selected (five controls for one 
ALS case) using incidence density sampling method and were matched to cases by gender 
and birth year.  Eligible controls should not have an ALS diagnosis on the index date of 
cases; however, they could develop ALS over follow-up and become an ALS case.   
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4.3.3.3 Exposure 
 
Occupation  
Occupation history was taken from the 1970, 1980 and 1990 Swedish Population and 
Housing Censuses.  Individuals in the censuses only have one occupation per census. In our 
study, we used three different censuses; we made it so that if a person had three different 
occupations throughout the censuses, they would be exposed to all three occupations.  
Among all of the Swedish censuses, occupations are organized by a three level ordering 
system; the first level, having one digit, uses the broadest category labels and the third level, 
has three digits, with the most specific category labels.  When analyzing occupations, we 
used administrative and clerical work (one of the largest occupation groups) as a reference 
group, since there is little literature supporting that it is associated with ALS and it likely does 
not have exposure to neurotoxicants (Sutedja et al., 2009).   
 
Occupational Exposure 
Using the Swedish version of the Nordic Occupational Cancer Study (NOCCA)-JEM, 
occupational exposures were assessed (Kauppinen et al., 2009).  Occupations are linked to 
workplace exposures in a JEM.  More than 20 agents, 300 occupations, and four different 
time periods (between 1945-1994) are included in the NOCCA-JEM (Kauppinen et al., 
2009).  Individual occupational exposures were created in the NOCCA-JEM by using various 
occupations that are at a three-digit level within the Swedish censuses.  Our study 
investigated chromium, nickel, lead, iron, benzo (a) pyrene, benzene, methylene chloride, 
trichloroethylene, 1,1,1,-trichloroethane, perchloroethylene, toluene, and formaldehyde, 
which have previously been suggested to be associated with ALS.  These exposures were 
then combined into three groups: formaldehyde, metals + benzo (a) pyrene (iron, chromium, 
nickel, lead, and benzo (a) pyrene), and solvents (benzene, methylene chloride, 
trichloroethylene, 1,1,1,-trichloroethane, perchloroethylene, and toluene).  More than 90% of 
occupations with exposures to metals or benzo (a) pyrene overlapped with one another.  
Because of this we combined metals + benzo (a) pyrene into an exposure group.  The 
reference group for occupational exposures consisted of individuals who were not exposed to 
the exposure of interest. 
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The NOCCA-JEM also explores prevalence and level of exposure at specific time points 
(Kauppinen et al., 2009).  Keeping this in mind, we investigated the dose-response 
relationship of lead and formaldehyde with ALS risk.  Lead and formaldehyde are two 
occupational exposures that have been investigated frequently in past studies (Fang et al., 
2009; Wang et al., 2014).  The prevalence of the exposure (P) and the yearly mean level of 
exposure (L) were multiplied for specific occupations within the censuses to create an 
exposure (P*L in mg/m
3
) (Kauppinen et al., 2009).  After this was completed, for each 
specific occupation group, P*L was calculated; then, it was averaged over the three censuses 
to create an exposure estimate for each individual.   
 
4.3.3.4 Statistical Analyses 
 
Statistical analyses 
To investigate the associations of ALS with occupations and occupational exposures we used 
conditional logistic regression models to estimate ORs and 95% CIs.  These models were 
conditioned on matching strata since cases and controls were matched on birth year and 
gender (male/female).  All models were additionally adjusted for education (9 years or less, 
10-12 years and university + PhD).   
 
Only occupations included in the censuses at least ten years before the index date were 
included in the study to avoid potential reverse causality.  We additionally restricted analyses 
to cases and controls that had at least one occupation in any of the censuses; this was done in 
order to minimize “healthy worker effect” (Shah, 2009).  Since the majority of Swedish 
workers retire at 65 years of age, we conducted a sensitivity analysis among those that were 
<65 years of age at index date. 
 
White collar workers are rare among occupational exposures; because of this we restricted the 
occupational exposure and dose-response analyses (for lead and formaldehyde) to cases and 
controls that were either blue collar workers or farmers.  In the models for analyzing 
occupational exposures, exposures were mutually adjusted for one another.  
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4.3.4 Study IV 
 
4.3.4.1 Cohort  
We used the PRN to link the Swedish Population and Housing Censuses for 1980 and 1990, 
the Cause of Death Register, the Swedish Register of Education, the Migration Register, and 
the NPR.  To be eligible for the study population, all individuals had to be included in either 
of the 1980 or 1990 census, alive, born between 1901 and 1956 and free from ALS on 
January 1
st
 1987 (the date when follow-up started).   
 
4.3.4.2 Outcome 
 
ALS diagnosis was identified with ICD codes from the NPR (main or secondary diagnoses) 
and had to be the first record of ALS within the NPR.   
 
4.3.4.3 Exposure 
The first record of fractures (minus head and face) was taken from the NPR and identified 
from ICD-7 through ICD-10.  Multiple fractures were not considered; a person could have 
multiple records for one fracture within the outpatient register. We created different 
categories for fractures: osteoporotic (wrist/forearm, rib, hip, or spine fractures)/non-
osteoporotic and fractures related to trauma/not related to trauma.  Using accident (abuse, 
manslaughter, murder, police abuse, falls, traffic related incidents, open fire, nature & 
environment, and other accidents) ICD codes (ICD-7 through ICD-10, Swedish revisions), 
fractures related to trauma were identified.   
 
4.3.4.4 Statistical Analyses 
 
From the date of entry, January 1
st
, 1987, until death, migration out of Sweden, date of first 
ALS diagnosis, or December 31
st
, 2010 (whichever occurred first), risk time (person-years) 
was accumulated.  Number of events per 100,000 person-years was calculated into incidence 
rates with 95% CIs.   
 
Using cox proportional hazards regression models (yielding hazard ratios (HRs) and 95% 
CIs) with attained age as the time scale we examined the relation between fractures and risk 
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of ALS.  For this analysis, a time-varying exposure was used; people contributed to 
unexposed risk time until they had a fracture diagnosis and after this they contributed to 
exposed time.  Models were adjusted for gender and the highest level of education.  The 
proportional hazards assumption was investigated with the χ2 test based on the Schoenfeld 
residuals.  Our main analyses were censored at ≤80 years of age; this was because the 
proportional hazards assumption was not met after 81 years of age. 
 
We also wanted to study time since fracture (any fracture (minus head and face)) and how 
that influenced ALS.  Two time scales (time since fracture and attained age) were split into 
monthly and yearly intervals, data collapsed by both time-scales and covariate patterns (sex 
and education), and then data was modelled using restricted cubic splines.  There was 46 
years of potential fracture time.  Those that had a diagnosis of fracture prior to start of follow-
up entered the study with the number of months that had passed since their diagnosis.  
Poisson regression models with restricted cubic splines were used to examine the association 
of time since fracture and ALS; this yielded HRs and 95 % CIs.  These models were 
additionally adjusted for the highest level of education and sex, with attained age and time 
since fracture as time-scales.  Five knots were used for the restricted cubic spline; using 
different numbers of knots changed the fracture and ALS association minimally.   
 
SAS version 9.3 or 9.4 (SAS Institute, North Carolina, USA) and Stata v.13 (Study IV) 
(StataCorp, College Station, TX, USA) were used to perform statistical analyses. 
 
Studies I, III, and IV were approved by the Regional Ethical Review Board in Stockholm, 
Sweden and the VALE study (study II) was approved by the Institutional Review Boards of 
the Durham VA Medical Center, National Institute of Environmental Health Science, 
Copernicus Group and Duke University. 
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5 RESULTS  
5.1 STUDY I 
 
In general, there were more men (56%) than women (44%) who had ALS in our study; 
additionally, most ALS patients were aged 70-79 (35%) and were either white collar (36%) 
or blue collar (34%) workers.  There was an association between first severe head injury, less 
than or equal to one year before index date (OR: 3.9, 95% CI: 2.6-6.1), and the risk of ALS 
(Table 1).  For the rest of the years before index date, there was no association between first 
severe head injury and the risk of ALS; for example:  > 3 years before index date had an OR 
of 1.2 with 95% CI of 0.9-1.5 (Table 1).  No associations were seen for repeated head injury 
and subtypes of head injury and the risk of ALS. 
 
Table 1. Severe head injury, years before index date, and the risk of amyotrophic 
lateral sclerosis. 
 ALS Cases  
No. 
Controls  
No. 
OR (95% CI)* 
No injury 3,888 19,632 Referent 
≤1 39 50 3.9 (2.6-6.1) 
>1 to ≤3 14 64 1.1 (0.6-1.9) 
>3 63 274 1.2 (0.9-1.5) 
*adjusted for socioeconomic status and region  
 
5.2 STUDY II 
 
For both cases and controls in our study, the average age was around 63 and most participants 
were ever smokers, white (non-hispanic) and men.  For ALS patients the majority had spinal 
onset and their main diagnoses were clinically probable ALS.   
Using AIC criterion, model fit was good for the continuous variables of Se, Zn, and Cu, 
whereas the categorical variable Mn had a better model fit than the continuous one.  In this 
study we found that Se (OR=0.4, 95% CI: 0.2-0.8) and Zn (OR=0.4, 95% CI: 0.2-0.8), after 
adjustment for age, gender and race/ethnicity, were inversely associated with the risk of ALS.  
Cu, after adjustment for age, gender and race/ethnicity, was positively associated (OR= 3.4, 
95% CI: 1.5-7.9) with the risk of ALS.  Finally, comparing the middle to the lowest 20%, 
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Mn, after adjustment for age, gender and race/ethnicity, was positively associated (OR= 2.3, 
95% CI: 1.2-4.3) with the risk of ALS (Table 2). 
Table 2. Association of selenium, zinc, copper and manganese with risk of amyotrophic lateral 
sclerosis. 
 Controls 
N=229 
N (%) 
ALS Cases 
N=163 
N (%) 
ALS 
OR (95% CI)* 
AIC 
Selenium (µg/dL)      
log2Se § 229 (100) 163 (100) 0.4 (0.2-0.8) 527.761 
Zinc (µg/dL)      
log2Zn § 229 (100) 163 (100) 0.4 (0.2-0.8) 528.888 
Copper (µg/dL)      
log2Cu § 229 (100) 163 (100) 3.4 (1.5-7.9) 526.060 
Manganese (µg/dL) †     
     ≥ 0.23 and ≤ 0.74 46   (20) 25   (15) 1.0 (Reference)  
     > 0.74 and ≤ 0.93 46   (20) 44   (27) 1.7 (0.9-3.3)  
     > 0.93 and ≤ 1.15 44   (19) 55   (34) 2.3 (1.2-4.3)  
     > 1.15 and ≤ 1.39 47   (21) 24   (15) 0.9 (0.5-1.9)  
     > 1.39 and ≤ 6.03 46   (20) 15   (9) 0.6 (0.3-1.3) 521.353 
* Adjusted for age, gender and race/ethnicity. 
§ Continuous metal variables were log2-transformed and OR corresponds to a doubling of the 
metal level.    
† Categorized at quintiles among the controls. 
 
 
 
Additionally adjusting Se, Zn, and Mn for 
smoking, lead, and all metals (lead, Se, Zn, 
Cu, and Mn in the same model) did not 
change any of the associations significantly 
with the risk of ALS.  However, when Cu 
was adjusted for lead, it changed the 
association (OR) between Cu and ALS 
from 3.4 (95% CI: 1.5-7.9) to 2.1 (95% CI: 
0.9-5.0) (Table 3). 
 
Considering ALS patients in different 
clinical categories (lower vs. higher 
ALSFRS-R score, shorter vs. longer 
collection delay, shorter vs. longer 
diagnostic delay, spinal vs. bulbar), there 
were no meaningful differences in 
Table 3. Association of selenium, zinc, copper 
and manganese with amyotrophic lateral 
sclerosis, adjusting for lead. 
 OR (95% CI)* 
Lead 
Selenium (log2Se, μg/dL) § 
 0.5 (0.2-1.0) 
Zinc (log2Zn, μg/dL) § 
 0.4 (0.2-0.8) 
Copper (log2Cu, μg/dL) § 
 2.1 (0.9-5.0) 
Manganese (µg/dL) †  
     ≥ 0.23 and ≤ 0.74 1.0 (Reference) 
     > 0.74 and ≤ 0.93 1.7 (0.9-3.4) 
     > 0.93 and ≤ 1.15 2.3 (1.2-4.4) 
     > 1.15 and ≤ 1.39 1.0 (0.5-2.0) 
     > 1.39 and ≤ 6.03 0.6 (0.3-1.4) 
*Adjusted for age, gender, race/ethnicity, and 
lead.  
§ Continuous metal variables were log2-
transformed and OR corresponds to a 
doubling of the metal level.    
† Categorized at quintiles among the controls. 
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concentrations of Cu and Mn.  For Zn, there were no differences in association with ALS by 
diagnostic delay and site of onset; however, there was a difference by ALSFRS-R score and 
collection delay; Zn was inversely associated with ALS among patients that had lower, but 
not higher, ALSFRS-R scores and longer, but not shorter, collection delay (Table 4).  For Se 
there were differences by ALSFRS-R score, collection delay, diagnostic delay, and site of 
onset (Table 4); strong inverse associations with ALS were observed among patients with 
lower ALSFRS-R scores, longer collection delay, longer diagnostic delay, and bulbar onset 
(Table 4).  
 
Table 4. Association of selenium and zinc with amyotrophic lateral 
sclerosis risk by clinical features. 
   OR (95% CI) * P-value † 
Selenium (μg/dL) § 
 ALSFRS-R Score ‡   
  ≤ 29 0.1 (0.04-0.3)  ≤ 0.01 
  > 29 1.7 (0.7-4.2)  
 Collection Delay (months)   
  ≤ 13 1.3 (0.5-3.1)  ≤ 0.01 
  > 13 0.1 (0.1-0.4)  
 Diagnostic Delay (years)   
  ≤ 1 0.7 (0.3-1.7)  0.03 
  > 1 0.2 (0.1-0.5)  
 Site of Onset   
  Spinal  0.6 (0.3-1.3)  ≤ 0.01 
  Bulbar 0.1 (0.03-0.3)  
Zinc (μg/dL) § 
 ALSFRS-R Score ‡   
  ≤ 29 0.2 (0.1-0.6)  0.09 
  > 29 0.7 (0.2-1.9)  
 Collection Delay (months)   
  ≤ 13 0.8 (0.3-2.2)  0.05 
  > 13 0.2 (0.1-0.6)  
 Diagnostic Delay (years)   
  ≤ 1 0.3 (0.1-0.7)  0.21 
  > 1 0.6 (0.2-1.6)  
 Site of Onset   
  Spinal  0.4 (0.2-1.0)  0.71 
  Bulbar 0.3 (0.1-1.2)  
* Adjusted for age, race/ethnicity.   
† Comparing ORs for ALS cases with the clinical features.   
§ Continuous metal variables were log2-transformed and OR 
corresponds to a doubling of the metal level.    
‡ Three ALS cases were omitted from the analysis because 
ALSFRS-R scores were missing. 
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5.3 STUDY III 
 
For this study, the majority of ALS cases were between the ages of 70-79 (34%), had ≤ 9 
years of education (47%), and were male (56%).  No associations were found for various 
occupations and the risk of ALS among the subgroup <65 years of age.  Among the total 
population positive associations existed with glass, pottery and tile work (OR: 1.76, 95% CI: 
1.03, 3.00), precision-tool manufacturing (OR: 1.68, 95% CI: 1.11, 2.52) and the risk of ALS, 
whereas we found an inverse association with textile work (OR: 0.44, 95% CI: 0.21, 0.91) 
and the risk of ALS.   
For occupational exposures, we found associations with ALS among the <65 years of age 
subgroup.  In the analyses for twelve separate occupational exposures, among the <65 years 
of age subgroup, we found formaldehyde to be positively associated with the risk of ALS 
(OR: 1.29, 95% CI: 1.00-1.65) and methylene chloride to be inversely associated with the 
risk of ALS (OR: 0.49, 95% CI: 0.26-0.93) (Table 5).   
 
   
Table 5. Exposures in occupations held at least 10 years before 
amyotrophic lateral sclerosis diagnosis and the risk of amyotrophic lateral 
sclerosis. 
 
Cases Controls   
 (N= 1014) (N= 4969) OR (95% CI)* 
No Exposure 639 3273  Reference 
Lead 288 1285 1.35 (0.94-1.93) 
Formaldehyde  140 576 1.29 (1.00-1.65) 
Iron 210 949 0.79 (0.25-2.47) 
Nickel  209 949 0.96 (0.33-2.82) 
Trichloroethylene 129 549 0.89 (0.57-1.37) 
Methylene chloride 125 648 0.49 (0.26-0.93) 
Chromium 237 1059 1.19 (0.68-2.08) 
Perchloroethylene 30 139 1.27 (0.63-2.57) 
Toluene 108 557 1.48 (0.49-4.49) 
Benzene 111 569 0.71 (0.27-1.90) 
Benzo (a) pyrene 168 782 1.02 (0.67-1.57) 
1,1,1-Trichloroethane 194 893 1.39 (0.85-2.28) 
*Restricted to individuals < 65 years of age and adjusted for age and 
gender (matching factors), education, and the 12 occupational exposures 
were mutually adjusted for one another. 
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When analyzing the grouped occupational exposures, in the <65 years of age subgroup, we 
found no associations with grouped metals plus benzo (a) pyrene or solvents exposures, while 
formaldehyde remained positively associated with the risk of ALS (OR: 1.28, 95% CI: 1.02-
1.61) after mutual adjustment (Table 6).  In the total population, we found no associations for 
the twelve separate occupational exposures, or the grouped occupational exposures and the 
risk of ALS.  Among the total population and the <65 years of age subgroup we did not find a 
clear dose-response association with ALS for lead and formaldehyde. 
 
Table 6.  Grouped occupational exposures and amyotrophic lateral sclerosis risk. 
 
Cases Controls  
 (N= 1014) (N= 4969) OR (95% CI)* 
No Exposure 639 3273 Reference 
† Metals + benzo (a) pyreneb 301 1365 1.15 (0.90-1.48) 
§ Solvents 225 1046 0.95 (0.73-1.24) 
Formaldehyde  140 576 1.28 (1.02-1.61) 
*Restricted to individuals < 65 years of age and adjusted for age and gender 
(matching factors), education, and the three occupational exposure groups were 
mutually adjusted for one another. 
†Includes lead, iron, nickel, chromium,  benzo (a) pyrene 
§Includes  toluene,  benzene,  trichloroethylene,  methylene chloride, 
perchloroethylene, and 1,1,1-trichloroethane 
 
5.4 STUDY IV 
 
This cohort study was evenly distributed between men and women and women were more 
likely to have a lower risk of ALS.  Additionally, most people received at least twelve years 
of education and those that received a graduate degree were more likely to have a higher risk 
of ALS.  We found all different types of fractures (osteoporotic/non-osteoporotic, trauma-
related/not trauma-related, and all fractures (minus head and face)) to be associated with an 
increased risk of ALS after adjusting for sex and education (with attained age as the time-
scale) (Table 7).  We also found when examining time since fracture that there was an 
increased risk of ALS between one (HR: 2.33, 95% CI: 2.04, 2.66) and eighteen years (HR: 
1.19, 95% CI: 1.01, 1.43) after fracture diagnosis. 
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Table 7. Different types of fractures and the incidence rates, & risk of amyotrophic lateral sclerosis. 
 
ALS 
Cases 
n=4,797 
Total Population
 a
 
n=4,362,214 
Incidence Rate per 
100,000 Person-years 
 
IR 95% CI HR
b
 95% CI 
All Fractures (minus head and face)       
    Unexposed
c
 4,134  4,193,005 5.77 5.60, 5.95 1.00  
    Exposed 663  727,563 11.37 10.53, 12.27 1.51 1.39, 1.65 
Type of Fracture       
    Unexposed
c
 4,134 4,193,005 5.77 5.60, 5.95 1.00  
    Exposure to Osteoporotic Fractures 294 343,114 13.41 11.96, 15.03 1.59 1.41, 1.79 
    Exposure to Other Fractures 369 384,449 10.14  9.15, 11.23 1.46 1.31, 1.63 
Fractures Related to Trauma       
    Unexposed
c
 4,134 4,193,005 5.77 5.60, 5.95 1.00  
    Exposure Related to Trauma 616 677,003 11.27 10.41, 12.19 1.50 1.37, 1.63 
    Exposure Not Related to Trauma 47 50,560 12.86 9.66, 17.11 1.80 1.35, 2.40 
a
Restricted to individuals ≤80 years old. 
b
HR and 95% CI estimated from a Cox regression model with attained age as the time-scale and adjustment for sex 
and education. 
c
Reference. 
 
6 DISCUSSION 
 
6.1 METHODOLOGICAL CONSIDERATIONS 
 
6.2 COHORT STUDY 
Cohort studies consist of a group of people that are followed over a length of time (Rothman, 
2002).  During a cohort study a specific disease is ascertained over time and people are 
usually exposed or unexposed to an exposure (Rothman, 2002).  We utilized a cohort study 
design in Study IV; our outcome (disease) was ALS, and people could either be exposed or 
unexposed to different types of fractures.  A cohort study will have a follow-up period; 
people must be free of the outcome and alive at the start of the follow-up period (Rothman, 
2002). Other eligibility criterion may occur (being a specific age or being part of a specific 
region); however, this is to be assessed from study to study.  For Study IV, our eligibility 
criterion consisted of: being included in either of the 1980 or 1990 census, alive, born 
between 1901 and 1956 and free from ALS on January 1
st
 1987 (the date when follow-up 
started).  Similarly, people can exit the cohort study; such exits can include death or 
developing the outcome (disease) (Rothman, 2002).  For Study IV, people exited the cohort 
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when they died, migrated out of Sweden, had their first ALS diagnosis, or December 31
st
, 
2010 (end of follow-up) occurred (whichever occurred first).  Strengths of a cohort study 
include: being able to calculate incidence rates, and examine multiple outcomes (Rothman, 
2002).  Cohort studies have their limitations as well: they are expensive and, require lots of 
time; potential confounders may not be assessed and people may be lost during follow-up 
(Rothman, 2002).  
 
6.3 CASE-CONTROL STUDY 
Case-control studies aim to achieve similar goals as the cohort study (Rothman, 2002).  Case-
control studies are often conducted because investigators can gain specific information about 
confounders, collect additional information in general, investigate rare diseases, and they are 
less costly and time consuming (Levin, 2003; Rothman, 2002).  In case-control studies, cases 
and controls are taken from a larger cohort.  Studies I and III were nested case-control 
studies; they were nested within a Swedish cohort.  In Studies I and III, cases were 
identified from the NPR and controls were identified by using incidence density sampling.  
Study II was a case-control study, cases were taken from the Veterans Affairs Registry and 
controls were taken from the GENEVA study.  In case-control studies, cases and controls are 
first identified and then exposure information is collected (Levin, 2003; Rothman, 2002).  
Studies I and III took head injury from the NPR, occupations from the 1970, 1980 and 1990 
Swedish Population and Housing Censuses, and occupational exposures information was 
assessed via a JEM.  Study II collected blood samples and medical records.  Disadvantages 
of using a case-control study include: hard to calculate incidence rate, selection bias can 
easily occur, and it is hard to infer causality (Levin, 2003). 
6.4 BIAS 
6.4.1 Selection and Information Bias 
Selection bias occurs when study procedures or other factors influence who is in the study 
(Rothman, 2002).  In Study II, selection bias might be a concern, as about 20% of ALS 
patients had a diagnosis of ALS 2 years or more before blood collection procedures occurred; 
this would make them longer survivors.  Cases and controls, in Study II, were invited and 
chose to give an additional blood sample (self-selection), introducing another form of 
selection bias.  For Studies I, III and IV, selection bias might not be a big concern, as 
follow-up for the cohorts was almost complete, and for Studies I and III, density sampling 
was applied for the nested case-control studies. 
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Recall bias occurs when a person gives information about an exposure after the disease has 
happened (Rothman, 2002).  Studies I, III, and IV are free from recall bias because we used 
medical records / census data that were recorded before the date of ALS.  Additionally, date 
of ALS diagnosis was recorded by medical records at time of hospital/outpatient visit.  Study 
II, utilized medical records and blood samples, making it free of recall bias.   
However, although, these studies are free of recall bias, they are not free from 
misclassification.  Head injury diagnosis (Study I), occupational information (Study III), 
fracture diagnosis (Study IV), and ALS diagnosis (Studies I, II, III, and IV) can all be 
misclassified in the Swedish registries and by neurologists.   
 
6.4.2 Confounding 
A confounder is a disease or occurrence that may affect the outcome (Rothman, 2002).  In 
general, a confounder must be associated with both the disease and the exposure.  In our 
studies we have dealt with confounders in different ways, we have matched cases and 
controls by age and gender (Studies I and III) and we have also adjusted for potential 
confounders (Studies I, II, III and IV).   
Potential confounders (in our studies) in relation to ALS include: age (older age), gender 
(being male), race/ethnicity (white, non-Hispanic), region (Guam has had the highest rates of 
in the world), and socioeconomic status/education (higher socioeconomic status, low level of 
education) (Al-Chalabi and Hardiman, 2013; Cronin et al., 2007; Henry et al., 2015; Plato et 
al., 2003; Sutedja et al., 2007).   
For various exposures, in general, age, gender, race/ethnicity, region, socioeconomic status, 
or education was related to them.  When we adjusted our statistical models for these potential 
confounders we saw an increase or decrease in the OR of the association. For Study IV, we 
also made use of directed acyclic graphs to identify potential confounders.   
Study I: We considered age, gender (these two variables were matching factors), 
socioeconomic status and region of residence as potential confounders.  
Study II: We considered age, gender, and race/ethnicity as potential confounders. 
Study III: We considered age, gender (these two variables were matching factors) and 
education as potential confounders.   
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Study IV: We considered age (used as a time scale), gender, and education as potential 
confounders.   
6.5 GENERAL DISCUSSION STUDY I 
 
This was a prospective study about head injury and ALS risk, in which subtypes of head 
injury, severe head injury, and repeated head injury in regards to the risk of ALS were 
examined.  Severe head injury as a risk factor for ALS has never been looked at before in 
Sweden. In this study we were unable to find any association between ALS and subtypes of 
head injury, severe head injury, and repeated head injury. There was an association of ALS 
with head injury ≤1 year before index date; however, we hypothesize this association may be 
due to reverse causality.  Loss of the ability to walk and/or having an incorrect gait assistive 
device can create a situation for head injury, especially concussions.  Furthermore, going to 
the hospital for a head injury may elicit considerations for other disorders, especially ones 
that are neurologically based; a diagnosis of ALS may be found at this time.  
Since our study relied on hospital records, the onset of ALS may have occurred three years 
prior to hospitalization (or the use of specialist services).  We tried to account for this by 
conducting our analyses three years or more before ALS diagnosis.  We found that severe 
head injury more than three years before the index date was not associated with ALS risk.  
Overall, head injury in relation to ALS has been repeatedly studied in the past and results are 
mixed (Chen et al., 2007; Chio et al., 1991; Fournier et al., 2015; Kondo and Tsubaki, 1981; 
Lehman et al., 2012; Mckee et al., 2010; Pearce et al., 2015; Savica et al., 2012).  Most 
frequently, researchers look at sports or accident related head injuries and then examine 
minor, repeated, and/or subtypes of head injury (Chen et al., 2007; Pearce et al., 2015; Turner 
et al., 2001; Williams et al., 1991).  For ALS patients with bulbar onset, a case-control study 
found an association between head injury (11-30 years before the last head injury) and the 
risk of ALS (Binazzi et al., 2009).  Schmidt et al., 2010 found that the ALS and head injury 
association may be modified by APOE genotypes.  More recently, ALS and head injury have 
been related/not related to CTE or TDP-43 (McKee et al., 2010; Fournier et al., 2015).  Next 
steps should include investigating exposures related to head injury and how they affect the 
risk of ALS, including: damaged blood vessels, broken skull bones, bruising brain tissue, 
intracranial pressure, intracranial bleeding, affected axons, and leaking of the cerebrospinal 
fluid from the head.  
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The strengths of our study include:  1) we used a prospective design (making it free of recall 
bias), and 2) our study sample is large.  We also had limitations; even though our study 
sample was large, the repeated head injury and subtypes of head injury analyses had small 
numbers because both the exposures and outcome are rare.  Furthermore, because ALS 
patients were identified from the registers, we were unable to get the patient’s clinical 
information and the exact date of onset.  Another potential limitation is that the outpatient 
register didn’t begin until 2001; we may have missed patients who received care in the OPR 
only before this time.     
6.6 GENERAL DISCUSSION STUDY II 
 
In our case-control study among US veterans, we found associations of ALS with all four 
metals, Mn, Se, Cu and Zn.  Our study found inverse associations between ALS and Se or Zn 
after adjusting for other known risk factors.  Cu was positively associated with ALS, but 
adjusting for Pb weakened the association.  For Mn, we observed a positive association with 
ALS at moderate, but not higher, levels.  Additionally, we found inverse associations of ALS 
with Se (lower ALSFRS-R scores, longer collection delay, longer diagnostic delay, and 
bulbar onset) and Zn (lower ALSFRS-R scores and longer collection delay) among different 
clinical categories.   
In our study, we found higher levels of Se in VALE controls than in other populations (Bocca 
et al., 2011; Heitland and Koster, 2006; Jain et al., 2014).  As mentioned above, this could be 
because of diet and other environmental circumstances.  We don’t believe that our 
methodology contributed to the inverse associations we found, as assay characteristics are not 
likely to be different among cases and controls.     
In general, metal studies (Mn, Se, Cu, and Zn) are usually positively vs. inversely associated 
with the risk of ALS, although results in general are mixed (usually no association or positive 
associations) (Bergomi et al., 2002; Nagata et al., 1985; Pamphlett et al., 2001; Roos et al., 
2013).  ALS patients usually have higher amounts of metal exposure (Mn, Se, Cu, and Zn) in 
their body vs. lower amounts of metal exposure (Kapaki et al., 1997; Nagata et al., 1985; 
Roos et al., 2013).  Future studies could examine different metal levels and survival in ALS 
patients, particularly Se and Zn.   
Our study has several strengths; we used a more stringent definition of ALS (clinically 
definite, probable, or probable lab-supported ALS) for our main analysis, thereby improving 
the external validity of our findings.  We were able to control for confounding (smoking, 
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lead, and all metals) in our models and clinical categories were considered when investigating 
the relation between Mn, Se, Cu, and Zn and the risk of ALS.  Our sample size was relatively 
large and we used a highly sensitive assay for metals, which allowed for better detection of 
metals, especially at lower levels.  
Our study also has limitations.  Our ALS cases might be a selected group of long survivors, 
as the delay from diagnosis to blood draw (13 months on average) was rather long.  
Furthermore, reverse causality is possible because blood collection occurred after cases were 
diagnosed.  Another limitation is that cases and controls could have had different diets 
affecting the levels of Se. 
 
6.7 GENERAL DISCUSSION STUDY III 
 
In this study, we found several occupations to be associated with the risk of ALS.  In 
particular, among the whole population we found precision-tool manufacturing and glass, 
pottery, tile and pottery work to be positively associated with the risk of ALS; whereas we 
found textile work to be inversely associated with the risk of ALS.  For occupational 
exposures, among those that were <65 years of age, we found formaldehyde to be positively 
associated with the risk of ALS and methylene chloride to be inversely associated with the 
risk of ALS.  However, we did not find any dose-response relationship among lead and 
formaldehyde and the risk of ALS.   
Results from formaldehyde and ALS risk studies have been mixed (Fang et al., 2009; 
Weisskopf et al., 2009).  It is uncertain why we would find an inverse association between 
methylene chloride and ALS risk among the <65 years of age subgroup.  No known inverse 
association between methylene chloride and ALS has been found to date (Fang et al., 2009); 
this should be further explored. 
Future studies should use a JEM to examine different occupational exposures than ones found 
in the literature and in this study, in relation to ALS risk.   
There are several strengths for our study; our study’s sample size is large and we 
prospectively collected occupation information, allowing for better exposure information.  
We were able to examine occupational exposures with the NOCCA-JEM, and this JEM 
allowed us to study specific occupational exposures in Sweden.  We minimized the risk of 
reverse causality by removing exposures with a ten year induction period.  There were also 
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limitations to this study.  Certain occupations may fall under multiple occupational 
exposures.  Data on occupations were only collected at 10 year intervals, thus if a person’s 
occupation changed during this period, it was not captured.    
 
6.8 GENERAL DISCUSSION STUDY IV 
 
In this cohort study, we found positive associations among all fractures (minus head and 
face), osteoporotic/non-osteoporotic fractures, and fractures related to trauma/not related to 
trauma and the risk of ALS.  Additionally, positive associations of ALS and fracture were 
found one to eighteen years after fracture diagnosis. 
We believe that poor bone health or the release of lead from bone may be the underlying 
cause of the association between ALS and fracture.  We have used different types of fractures 
as a potential proxy to evaluate this association.  Previous studies have shown bone turnover 
and lead to be associated with the risk of ALS (Campbell et al., 1970; Fang et al., 2010).  
Lead can be released from bone when people become more sedentary; people often tend to 
slow down as they get older (Nash et al., 2004).  The associations of fracture and ALS from 
one to ten years maybe due to potential reverse causality (only about 10% of ALS patients 
survive longer than ten years (Ingre et al., 2015)), however, the findings from eleven-eighteen 
years may be indicative of a true association.  If fractures are to be examined in the future as a 
risk factor for ALS, it would be good to investigate lead and bone turnover measurements as 
potential mediators.  Also, muscle may play an important role with bone health and the risk 
of ALS (Zhou et al., 2015).  How does muscle, bone and lead relate to ALS?  Measurements 
of muscle could also be explored in relation to these research questions. 
Several strengths exist for this cohort study.  First, our sample size was large and we utilized 
first date of diagnosis for ALS and all fractures.  All accidents were eliminated among the not 
related to trauma exposure group; this allows for fractures found to have occurred because of 
a pathological condition and to reduce potential reverse causality.  We also conducted an 
analysis to examine time since fracture and the association with ALS.  
Limitations were also present in our cohort study.  Fractures were used as a proxy for the 
lead/bone turnover hypothesis versus examining direct effects.  There is potentiality for the 
misclassification of fracture codes and accidents; fractures may not have been properly 
captured in the Swedish Patient Register, as fractures can be treated in primary care services, 
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outpatient services and hospitals.  We were not able to investigate multiple fractures or 
specific clinical data for ALS (such as date and site of onset) because of the limitations of the 
NPR data. 
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7 CONCLUSIONS 
 
• Study I: Severe head injury, subtypes of head injury and repeated head injury is 
 not associated with ALS risk.  
     
 
• Study II:  Se and Zn are inversely associated with ALS risk.  Cu is positively 
associated with ALS risk, although, further adjustment for Pb attenuates this 
association.  Se is inversely associated with the risk of ALS by many different 
clinical features and Zn is inversely associated with ALS for only a few clinical 
features.   
 
 
 
• Study III:  We found an inverse association for textile work and a positive  
association for glass, pottery, and tile work, and precision-tool manufacturing  
with the risk of ALS.  For occupational exposures we only found a positive  
association for formaldehyde and an inverse association with methylene  
chloride for the risk of ALS among the subgroup of people < 65 years of age. 
 
 
 
 
• Study IV:  Different types of fractures were positively associated with the risk  
of ALS.  This positive association persisted one to eighteen years after fracture  
diagnosis. 
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